Company / Return on Assets (ROA)
ROCKET PHARMACEUTICALS, INC. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-78.3%
FY2025
5-year range
-78.3% / -15.6%
FY2021-FY2025
Trend
-86.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has declined for 5 consecutive years, from -12.6% in FY2020 to -78.3% in FY2025.
Based on SEC 10-K filings.
-78.3% in FY2025 with a 5-year CAGR of -65.7%.
Declined from -29.8% to -78.3% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -53.0pp
- 5-Year Change
- -65.7pp
- 10-Year Change
- -
Key checks
Key Insights
- ROCKET PHARMACEUTICALS, INC.'s return on assets (roa) has declined for 5 consecutive years.
- In FY2025, return on assets (roa) decreased 86.3% year-over-year.
- Peak return on assets (roa) was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -78.3% | -86.3% |
| FY2024 | -42.0% | -40.8% |
| FY2023 | -29.8% | -17.9% |
| FY2022 | -25.3% | -62.8% |
| FY2021 | -15.6% | -23.3% |
| FY2020 | -12.6% | +37.0% |
| FY2019 | -20.0% | -565.4% |
| FY2018 | -3.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026